Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.
Loading...
Identifiers
Publication date
2019
Start date of the public exhibition period
End date of the public exhibition period
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Oncogene
Share
Abstract
The global downregulation of microRNAs (miRNAs) is emerging as a common hallmark of cancer. However, the
mechanisms underlying this phenomenon are not well known. We identified that the oncogenic miR-146b-5p attenuates
miRNA biosynthesis by targeting DICER1 and reducing its expression. DICER1 overexpression inhibited all the miR-146binduced
aggressive phenotypes in thyroid cells. Systemic injection of an anti-miR-146b in mice with orthotopic thyroid
tumors suppressed tumor growth and recovered DICER1 levels. Notably, DICER1 downregulation promoted proliferation,
migration, invasion, and epithelial-mesenchymal transition through miRNA downregulation. Our analysis of The Cancer
Genome Atlas revealed a general decrease in DICER1 expression in thyroid cancer that was associated with a worse clinical
outcome. Administration of the small-molecule enoxacin to promote DICER1 complex activity reduced tumor
aggressiveness both in vitro and in vivo. Overall, our data confirm DICER1 as a tumor suppressor and show that
oncogenic miR-146b contributes to its downregulation. Moreover, our results highlight a potential therapeutic application of
RNA-based therapies including miRNA inhibitors and restoration of the biogenesis machinery, which may provide
treatments for thyroid and other cancers.